Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shu-Hong Bu"'
Autor:
Shu-Hong Bu, Jia Zhou, Jihui Chen, Xiaohui Huang, Xiaowen Guo, Jian Zhang, Li-Xia Li, Xiaoxiao Chen, Xin-Zhu Liu
Publikováno v:
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives, Vol 9, Iss 6, Pp n/a-n/a (2021)
Pharmacology Research & Perspectives, Vol 9, Iss 6, Pp n/a-n/a (2021)
To assess the pharmacokinetic parameters of vancomycin in Chinese critically ill pediatric patients, children treated with vancomycin, hospitalized in the intensive care unit were included. Samples to determine peak and trough serum concentrations we
Autor:
Zeyuan Wang, Jihui Chen, Jian Jian Zhang, Xiaohui Huang, Fei Gao, Zhiyan Lin, Peng Yu, Ze Yu, Wenjun He, Shu-Hong Bu, Xin Hao
Publikováno v:
Drug Design, Development and Therapy
Xiaohui Huang,1,* Ze Yu,2,* Shuhong Bu,1 Zhiyan Lin,1 Xin Hao,3 Wenjun He,2 Peng Yu,2 Zeyuan Wang,2 Fei Gao,2 Jian Zhang,1 Jihui Chen1 1Department of Pharmacy, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Rep
Autor:
Zeyuan Wang, Li-Xia Li, Shu-Hong Bu, Xin Wei, Jihui Chen, Xiaohui Huang, Junfeng Shi, Jian Zhang, Fei Gao, Yu Wang, Ajing Xu, Ze Yu
Publikováno v:
Expert review of clinical pharmacology. 14(6)
Despite therapeutic vancomycin is regularly monitored, its dose requirements vary considerably between individuals. Various innovative vancomycin dosing strategies have been developed for dose optimization; however, the utilization of individual fact
Autor:
Shu-Hong Bu, Hui-Juan Yao, Jihui Chen, You Yin, Ting Chen, Li-Xia Li, Xin-Zhu Liu, Yan Liu, Xiao-Tong Lu, Jian Zhang
Publikováno v:
Pharmacology. 95:279-284
This study explored nephrotoxicity in elderly Chinese patients after exposure to vancomycin and other nephrotoxic risk factors. This was a single-center retrospective study. The patient population included those who were ≥60 years of age, had norma
Publikováno v:
Molecular Biology Reports. 41:6263-6273
This meta-analysis was performed to assess the relationships between the PON1 Q192R (rs662 T>C) polymorphism and the clinical outcome of antiplatelet treatment after percutaneous coronary intervention (PCI). A range of electronic databases were searc
Autor:
Feiyan Lin, Saori Yonekubo, Levent Donmez, Nasr A. Sinjilawi, Friederike Traunmüller, Yingze Zhang, Maha A. Al-Amin, Markus Rothenburger, Jin-Hua Liu, Hanaa N. Al-Ajmi, Ran Sun, Hui-Juan Yao, Jian-Ping Cai, Xiaofeng Wang, Li Wang, Ramazan Cetinkaya, F. Fevzi Ersoy, Xin-Zhu Liu, Yangming Zheng, Leila Moezi, Neri Pucci, Julia Jückstock, Simona Barni, Nawal M. Al-Rasheed, Klaus Friese, Elio Novembre, Mahsa Hosseini, Gultekin Suleymanlar, Zaishou Zhuang, Kumi Tsuchioka, Guo-Xin Hu, Ji-Hui Chen, Shenshen Zhu, Li-Xia Li, Francesca Mori, Wan-Shu Li, Jun Hou, Heqing Tang, Hila M. Ene, Lufeng Hu, Fei Wang, Eckhard Beubler, Hala A. Attia, Kazuyasu Maruyama, Jingqing Chen, Ji-Hong Hu, Xiao-Tong Lu, Jian Zhang, Baicheng Chen, Han Li, Shu-Hong Bu, Wei Fang, Peter Dittrich, Sadi S. Ozdem, Yan Liu, Haim Einat, Iman H. Hasan, Lucrezia Sarti, Lisa Pecorari, Qibin Ke, Da-Peng Dai, Raeesa A. Mohamad, Vural Taner Yilmaz, Satoshi Tatemichi, Hamed Shafaroodi, You Yin, Sebahat Ozdem, Mengmeng Tang, Nirit Z. Kara, Ting Chen, Nouf M. Al-Rasheed, Xiangdi Yu, Hossein Niknahad, Druckerei Stückle, Mamoru Kobayashi, Simin Oveisi, Chun Chen
Publikováno v:
Pharmacology. 95
Publikováno v:
Molecular Biology Reports. 42:1477-1477
This meta-analysis was performed to assess the relationships between the PON1 Q192R (rs662 T>C) polymorphism and the clinical outcome of antiplatelet treatment after percutaneous coronary intervention (PCI). A range of electronic databases were searc